EEG Recordings and Analysis in Parkinson's Patients: Towards Adaptive Deep Brain Stimulation by Machine Learning

NCT ID: NCT05284526

Last Updated: 2023-08-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-09

Study Completion Date

2023-04-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this protocol is to obtain on Parkinson's disease more accessible therapeutic targets than deep brain stimulation (HFS-STN), the neurosurgical treatment for this pathology. This study will pave the way for new forms of adaptive processing for the HFS-STN. It could become functionally coupled to a minimalist EEG centred on the motor cortex and to software for decoding, live or slightly delayed, classes of movements performed. On the one hand, this device could be used as a sensor of the quality of the information transmitted by the cortical network, thus allowing the selection of the optimal parameters of the HFS-STN on the basis of the movement decoding score. On the other hand, this device could lead to adapting the HFS-STN treatment over time by regularly calculating the recognition scores of the different movements performed and comparing them to the initial scores.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

One of the therapies for Parkinson's disease, a condition affecting nearly 150,000 patients in France, is the invasive neurosurgical implantation of high-frequency deep brain stimulation of the subthalamic nuclei (HFS-STN). Although HFS-STN is very effective, the underlying mechanisms are still relatively poorly understood, particularly at the cortical level, a region that could become an alternative therapeutic target because it is easier to access. This study aims to measure the changes induced by the antiparkinsonian drug treatment and the HFS-STN on the encoding and transmission of motor information at the level of the motor cortex, thanks to the recording of the electroencephalogram of patients. These recordings, made during the performance of certain movements, will be subjected to an analysis using "machine learning" methods that will make it possible to decode the identity of the movement performed more or less efficiently.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

parkinsonian patients with and without dopaminergic drug treatment

Electroencephalogram (EEG) of 10 parkinsonian subjects with and without dopaminergic drug treatment during the preparation and execution of movements

Group Type EXPERIMENTAL

electroencephalogram (EEG) of control and parkinsonian subjects during the preparation and execution of movements

Intervention Type OTHER

electroencephalogram (EEG) of control and parkinsonian subjects during the preparation and execution of movements

parkinsonian patients with and without High-frequency stimulation of the subthalamic nucleus

Electroencephalogram (EEG) of 10 parkinsonian subjects with and without High-frequency stimulation (HFS) of the subthalamic nucleus (STN) during the preparation and execution of movements

Group Type EXPERIMENTAL

electroencephalogram (EEG) of control and parkinsonian subjects during the preparation and execution of movements

Intervention Type OTHER

electroencephalogram (EEG) of control and parkinsonian subjects during the preparation and execution of movements

control subjects

Electroencephalogram (EEG) of control subjects during the preparation and execution of movements

Group Type ACTIVE_COMPARATOR

electroencephalogram (EEG) of control and parkinsonian subjects during the preparation and execution of movements

Intervention Type OTHER

electroencephalogram (EEG) of control and parkinsonian subjects during the preparation and execution of movements

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electroencephalogram (EEG) of control and parkinsonian subjects during the preparation and execution of movements

electroencephalogram (EEG) of control and parkinsonian subjects during the preparation and execution of movements

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients :

1. Patient over 18 years of age
2. Patient meeting the clinical diagnostic criteria for Parkinson's disease (Postuma et al, Mov Dis, 2015)
3. Signed consent to participate in the study
4. Absence of cognitive impairment (MoCA\>24)
5. Affiliation to a French social security scheme

Healthy volunteer :

1. Healthy volunteer over 18 years of age
2. Signed consent to participate in the study
3. Absence of cognitive disorders (MoCA\>24)
4. Affiliation to a French social security system

Exclusion Criteria

Patients :

1. Patient refusal to participate
2. Pregnancy or breastfeeding in progress
3. Participation in another therapeutic interventional study
4. Patient under guardianship or curatorship
5. Person subject to a legal protection measure

Healthy volunteers :

1. Refusal of the healthy volunteer to participate
2. Pregnancy or breastfeeding in progress
3. Participation in another therapeutic interventional study.
4. Patient under guardianship or curatorship
5. Person subject to a legal protection measure
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

DEGOS

Bobigny, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Ashkan K, Rogers P, Bergman H, Ughratdar I. Insights into the mechanisms of deep brain stimulation. Nat Rev Neurol. 2017 Sep;13(9):548-554. doi: 10.1038/nrneurol.2017.105. Epub 2017 Jul 28.

Reference Type BACKGROUND
PMID: 28752857 (View on PubMed)

Liao K, Xiao R, Gonzalez J, Ding L. Decoding individual finger movements from one hand using human EEG signals. PLoS One. 2014 Jan 8;9(1):e85192. doi: 10.1371/journal.pone.0085192. eCollection 2014.

Reference Type BACKGROUND
PMID: 24416360 (View on PubMed)

Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 1995 Jan 14;345(8942):91-5. doi: 10.1016/s0140-6736(95)90062-4.

Reference Type BACKGROUND
PMID: 7815888 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHP211327

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Connectomic Guided DBS for Parkinson's Disease
NCT06618157 ENROLLING_BY_INVITATION NA
Deep Brain Stimulation and Parkinson's Disease
NCT02795663 COMPLETED EARLY_PHASE1